Arcutis Biotherapeutics, Inc. (ARQT)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Arcutis Biotherapeutics, Inc. chart...

About the Company

We do not have any company description for Arcutis Biotherapeutics, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

269

Exchange

Nasdaq

$M

Total Revenue

269

Employees

$847M

Market Capitalization

-2.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ARQT News

Industry Analysts Just Made A Captivating Upgrade To Their Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenue Forecasts

7h ago, source:

Arcutis Biotherapeutics, Inc. ( NASDAQ:ARQT ) shareholders will have a reason to smile today, with the analysts ...

Evaluating Arcutis Biotherapeutics: Insights From 5 Financial Analysts

14d ago, source:

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Arcutis Appoints David Topper as Chief Financial Officer

16d ago, source:

We could not be more pleased to welcome David as chief financial officer at this transformational time,” said Frank Watanabe, ...

Innovative Seborrhea Treatments on the Horizon as Pipeline Report Reveals Promising Drug Candidates for 2024

8h ago, source: Yahoo Finance

Among these promising candidates, Arcutis Biotherapeutics Inc. leads with ARQ154, a topical roflumilast foam currently in phase II of clinical development. The aim is to improve the quality of life ...

The Business Case For Buying Arcutis Biotherapeutics Inc (NASDAQ: ARQT) Stock Now

10d ago, source:

A look at the daily price movement shows that the last close reads $10.20. The company’s 5Y monthly beta was ticking 1.14.

Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?

2d ago, source: Zacks.com on MSN

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has AdaptHealth Corp. (AHCO) been one of those stocks this year? By taking a look at ...

Analysts Advise You To Maintain Your Position In Arcutis Biotherapeutics Inc (NASDAQ: ARQT)

18d ago, source:

Arcutis Biotherapeutics Inc (NASDAQ:ARQT) traded at $11.34 at close of the session on Friday, April 05, made an upward move of 5.49% on its previous day’s price.

Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?

18d ago, source: Zacks.com on MSN

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. AdaptHealth Corp. (AHCO) is a stock that can certainly grab the attention of many ...

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

20d ago, source: TMCnet

WESTLAKE VILLAGE, Calif., April 05, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...

Excision BioTherapeutics Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

16d ago, source: TMCnet

Excision to give three oral presentations and outline new data in three posters from preclinical programs for herpes keratitis (HSV-1 Keratitis) and hepatitis B virus (HBV) as well as a ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...